caa a22 4500 477061605 CHVBK 20180405111402.0 cr unu---uuuuu 170330e19960301xx s 000 0 eng 10.1007/BF01061911 doi (NATIONALLICENCE)springer-10.1007/BF01061911 Elliott C. Pulmonary Division, LDS Hospital and University of Utah School of Medicine, Salt Lake City, Utah aut Thrombolysis for acute pulmonary embolism: Are the risks worth the benefits? [Elektronische Daten] [C. Elliott] The successful application of thrombolytic therapy to the treatment of acute myocardial infarction has stimulated similar attempts to apply thrombolytic therapy to the treatment of acute pulmonary embolism. The development of newer thrombolytic agents and improved protocols for dosing and delivering thrombolytic therapy have provided additional insight into the risks and potential benefits of thrombolysis for acute pulmonary embolism. The purpose of the present review is to examine the risks and benefits of thrombolytic therapy for pulmonary embolism in light of recent investigations. Kluwer Academic Publishers, 1996 acute pulmonary embolism nationallicence thrombolysis nationallicence risk nationallicence benefit nationallicence blood transfusion nationallicence Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 2/4(1996-03-01), 275-278 0929-5305 2:4<275 1996 2 11239 https://doi.org/10.1007/BF01061911 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01061911 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Elliott C. Pulmonary Division, LDS Hospital and University of Utah School of Medicine, Salt Lake City, Utah aut NATIONALLICENCE 773 0- Journal of Thrombosis and Thrombolysis Kluwer Academic Publishers 2/4(1996-03-01), 275-278 0929-5305 2:4<275 1996 2 11239 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer